Key points from article :
People with IBD are at a 28% higher risk of developing Parkinson's disease.
Anti-Tumor Necrosis Factor alpha therapy used against inflammatory bowel disease.
After anti-TNF? therapy risk of Parkinson's lower than that in the general population.
78% reduction in Parkinson's disease among IBD patients treated with anti-TNF?.
The study was published in the JAMA Neurology journal.
